peer review

key opinion leaders respond to the geko™ device

During the development of the geko™ devices, key figures have provided feedback...

Professor T. Briggs

Medical Director, Royal National Orthopaedic Hospital

"I am excited by the potential of this novel device to prevent significant adverse events in a high risk, high volume population".

According to the National Joint Registry over 150,000 lower limb arthroplasty procedures were carried out throughout the UK in 2008. Thromboembolic phenomena are a significant and common risk following these operations. DVT prophylaxis is by medical therapy and by prevention of blood stasis.

We are keen to examine the effect of the neuromuscular stimulator to lower the risk of post-operative DVT both directly and indirectly via increased ambulation.


David Warwick, MD BM FRCS FRCS(Orth)

Reader in Orthopaedic Surgery
Wessex Nuffield Hospital, Southampton, SO53 2DW

"The geko™ device offers the potential for effective, affordable and convenient thromboprophylaxis".

Venous thromboembolism is an important, and largely preventable, problem in orthopaedic surgery. Mechanical methods are intuitively attractive as they can reduce the risk without introducing the alternative risk of bleeding that is associated with chemical methods. Existing mechanical methods rely on sequential or impulse compression. These devices are relatively cumbersome and expensive. Electrical stimulation showed encouraging results very many years ago and the technology warrants a revisit. The geko™ device offers the potential for effective, affordable and convenient thromboprophylaxis.


Professor Ajay Kakkar

Director of the Thrombosis Research Institute, London

"This technology has the potential to provide a paradigm shift in thrombosis prevention".